BALPHARMANSEBal Pharma Limited· PharmaceuticalsMediumNegative
Announced Tue, 12 May · 12:35 IST

Bal Pharma Limited has informed the Exchange about Resignation of Director/KMP/SMP

Kmp ResignedManagement Changes View source PDF

BALPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-8.0%1-day move
₹87.00
prior close
₹83.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.9-0.5-0.5-0.3-8.0-9.7-7.5-11.0-9.5-2.9+0.1-1.0-9.6
Up moveDown movePending
AI summary

Mr. Abdul Basith, Company Secretary & Compliance Officer (also Deputy Nodal Officer) of Bal Pharma Limited, has tendered his resignation effective 11th May 2026. He submitted his resignation letter dated 2nd March 2026, citing his decision to pursue alternate career opportunities outside the company. The resignation was accepted by the Board on 11th May 2026. The company has stated that communications should be sent to secretarial@balpharma.com until a new Company Secretary & Compliance Officer is appointed.

Likely market impact

The departure of the Company Secretary & Compliance Officer (a Key Managerial Personnel) leaves a compliance gap at the top management level. Investors should monitor for timely appointment of a replacement to ensure regulatory compliance requirements under SEBI Listing Regulations are met.